Polymerase chain reaction in the detection of tumor cells: New approaches in diagnosis and follow-up of patients with thyroid cancer

Thyroid

Volumn 12, Issue 12, 2002, Pages 1097-1107

  Bojunga, Jörg ^a   Kusterer, Klaus ^a   Schumm Draeger, Petra Maria ^a   Usadel, Klaus Henning ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; HERMES ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; MUCIN 1; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER; TELOMERASE; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR;

ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER RECURRENCE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; METASTASIS; MOLECULAR BIOLOGY; ONCOGENE RET; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; TUMOR CELL;

EID: 0036963755     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072502321085199     Document Type: Review

References (88)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83:2638-2648.
2. Correa P, Chen VW 1995 Endocrine gland cancer. Cancer 75:338-352.
3. Parker SL, Tong T, Bolden S, Wingo PA 1997 Cancer statistics, 1997. CA Cancer J Clin 47:5-27.
4. Franceschi S, Boyle P, Maisonneuve P, La Vecchia C, Burt AD, Kerr DJ, MacFarlane GJ 1993 The epidemiology of thyroid carcinoma. Crit Rev Oncogene 4:25-52.
5. Pettersson B, Coleman MP, Ron E, Adami HO 1996 Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 65:13-19.
6. Loh KC, Greenspan FS, Gee L, Miller TR, Yeo P 1997 Pathological tumor-node-metastasis (pTNM) staging of papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients. J Clin Endocrinol Metab 82:3553-3562.
7. Noguchi M, Katev N, Miwa K 1998 Therapeutic strategies and long-term results in differentiated thyroid cancer. J Surg Oncol 67:52-59.
8. Johnson PW, Burchill SA, Selby PJ 1995 The molecular detection of circulating tumour cells. Br J Cancer 72:268-276.
9. Haber RS 1998 Editorial: The diagnosis of recurrent thyroid cancer - A new approach. J Clin Endocrinol Metab 83:4189-4190.
10. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG, Gomella LG 1992 Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52:6110-6112.
11. Mattano LA, Moss TJ, Emerson SG 1992 Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52:4701-4705.
12. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS 1994 Sensitive detection of occult breast cancer by the reverse- transcriptase polymerase chain reaction. J Clin Oncol 12:475-482.
13. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF, Rosai J 1995 Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: Clinical implications. J Clin Oncol 13:1195-1200.
14. Ghossein RA, Rosai J 1996 Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78:10-16.
15. Jonas S, Windeatt S, Boateng A, Fordy C, Allen-Mersh TG 1996 Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 39:717-721.
16. Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schlimok G, Riethmuller G, Pantel K 1997 Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701-2708.
17. Ko Y, Klinz M, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H 1998 Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res 4:2141-6.
18. Seiter S, Rappl G, Tilgen W, Ugurel S, Reinhold U 2001 Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR. Recent Results Cancer Res 158:105-112.
19. La Rosa GL, Belfiore A, Giuffrida D, Sicurella C, Ippolito O, Russo G, Vigneri R 1991 Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer 67:2137-2141.
20. Greenspan FS 1997 The role of fine-needle aspiration biopsy in the management of palpable thyroid nodules. Am J Clin Pathol 108:S26-30.
21. Hamburger JI 1994 Diagnosis of thyroid nodules by fine needle biopsy: Use and abuse. J Clin Endocrinol Metab 79:335-339.
22. Zrihan-Licht S, Weiss M, Keydar I, Wreschner DH 1995 DNA methylation status of the MUC1 gene coding for a breast-cancer- associated protein. Int J Cancer 62:245-251.
23. Bieche I, Ruffet E, Zweibaum A, Vilde F, Lidereau R, Franc B 1997 MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid. Thyroid 7:725-731.
24. Weiss M, Baruch A, Keydar I, Wreschner DH 1996 Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene. Int J Cancer 66:55-59.
25. Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R, Filetti S 1997 Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82:1638-1641.
26. Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A 1998 Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res 58:4193-4198.
27. Ruschenburg I, Kubitz A, Schlott T, Korabiowska M, Droese M 1999 MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter. Int J Mol Med 4:445-448.
28. Itoh K, Hayashi A, Nakao M, Hoshino T, Seki N, Shichijo S 1996 Human tumor rejection antigens MAGE. J Biochem (Tokyo) 119:385-390.
29. Rudzki Z, Jothy S 1997 CD44 and the adhesion of neoplastic cells. Mol Pathol 50:57-71.
30. Takano T, Sumizaki H, Amino N 1997 Detection of CD44 variants in fine needle aspiration biopsies of thyroid tumor by RT-PCR. J Exp Clin Cancer Res 16:267-271.
31. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A 1999 Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494-3502.
32. Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A 1998 Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 58:3015-3020.
33. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T 1999 Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475-2484.
34. Lloyd RV 2001 Distinguishing benign from malignant thyroid lesions: Galectin 3 as the latest candidate. Endocr Pathol 12:255-257.
35. Orlando C, Gelmini S 2001 Telomerase in endocrine and endocrine-dependent tumors. J Steroid Biochem Mol Biol 78:201-214.
36. Aogi K, Kitahara K, Urquidi V, Tarin D, Goodison S 1999 Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid. Clin Cancer Res 5:2790-2797.
37. Sebesta J, Brown T, Williard W, Dehart MJ, Aldous W, Kavolius J, Azarow K 2001 Does telomerase activity add to the value of fine needle aspirations in evaluating thyroid nodules? Am J Surg 181:420-422.
38. Saji M, Xydas S, Westra WH, Liang CK, Clark DP, Udelsman R, Umbricht CB, Sukumar S, Zeiger MA 1999 Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res 5:1483-1489.
39. Zeiger MA, Smallridge RC, Clark DP, Liang CK, Carty SE, Watson CG, Udelsman R, Saji M 1999 Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery 126:1195-1198; discussion, 1198-1199.
40. Takano T, Matsuzuka F, Sumizaki H, Kuma K, Amino N 1997 Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. Cancer Res 57:3792-3797.
41. Takano T, Matsuzuka F, Miyauchi A, Yokozawa T, Liu G, Morita S, Kuma K, Amino N 1998 Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study. Br J Cancer 78:221-224.
42. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Liu G, Higashiyama T, Morita S, Kuma K, Amino N 1998 Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res 58:4913-4917.
43. Higashiyama T, Takano T, Matsuzuka F, Liu G, Miyauchi A, Yokozawa T, Morita S, Kuma K, Shiba E, Noguchi S, Amino N 1999 Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction. Thyroid 9:235-240.
44. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, Kuma K, Amino N 1999 Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 59:4542-4545.
45. Takano T, Shiba E, Tada H, Yoshimura H, Yoshida K, Doi R, Amino N 2000 Preoperative diagnosis of thyroid carcinomas by aspiration biopsy- reverse transcription-polymerase chain reaction (ABRP): A report of two cases. Endocr J 47:271-275.
46. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL 2001 Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 86:2187-2190.
47. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G 1990 PTC is a novel rearranged form of the ret protooncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563.
48. Chiappetta G, Toti P, Cetta F, Giuliano A, Pentimalli F, Amendola I, Lazzi S, Monaco M, Mazzuchelli L, Tosi P, Santoro M, Fusco A 2002 The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol Metab 87:364-369.
49. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F 2001 RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-3216.
50. Marsh DJ, Learoyd DL, Robinson BG 1995 Medullary thyroid carcinoma: recent advances and management update. Thyroid 5:407-424.
51. Heshmati HM, Gharib H, van Heerden JA, Sizemore GW 1997 Advances and controversies in the diagnosis and management of medullary thyroid carcinoma. Am J Med 103:60-69.
52. Giuffrida D, Gharib H 1998 Current diagnosis and management of medullary thyroid carcinoma. Ann Oncol 9:695-701.
53. Russo D, Arturi F, Chiefari E, Meringolo D, Bianchi D, Bellanova B, Filetti S 1997 A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens. J Clin Endocrinol Metab 82:3378-3382.
54. Takano T, Miyauchi A, Matsuzuka F, Liu G, Higashiyama T, Yokozawa T, Kuma K, Amino N 1999 Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 84:951-955.
55. Bugalho MJ, Mendonca E, Sobrinho LG 2000 Medullary thyroid carcinoma: An accurate pre-operative diagnosis by reverse transcription-PCR. Eur J Endocrinol 143:335-338.
56. Lloyd RV, Sisson JC, Marangos PJ 1983 Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma. Cancer 51:2234-2239.
57. Zajac JD, Penschow J, Mason T, Tregear G, Coghlan J, Martin TJ 1986 Identification of calcitonin and calcitonin generelated peptide messenger ribonucleic acid in medullary thyroid carcinomas by hybridization histochemistry. J Clin Endocrinol Metab 62:1037-1043.
58. Santoro M, Rosati R, Grieco M, Berlingieri MT, D'Amato GL, de Franciscis V, Fusco A 1990 The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595-1598.
59. Herle AJ, Uller RP 1975 Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 56:272-277.
60. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT 1999 Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 9:435-441.
61. Duren M, Siperstein AE, Shen W, Duh QY, Morita E, Clark OH 1999 Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients. Surgery 126:13-19.
62. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR, III, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885.
63. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127.
64. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, Lo Gerfo PL 1996 Detection of circulating thyroid cells in peripheral blood. Surgery 120:959-964; discussion 964-965.
65. Tallini G, Ghossein RA, Emanuel J, Gill J, Kinder B, Dimich AB, Costa J, Robbins R, Burrow GN, Rosai J 1998 Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 16:1158-1166.
66. Ringel MD, Ladenson PW, Levine MA 1998 Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83:4435-4442.
67. Wingo ST, Ringel MD, Anderson JS, Patel AD, Lukes YD, Djuh YY, Solomon B, Nicholson D, Balducci-Silano PL, Levine MA, Francis GL, Tuttle RM 1999 Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 45:785-789.
68. Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM 1999 Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 84:4037-4042.
69. Fenton C, Anderson JS, Patel AD, Lukes Y, Solomon B, Tuttle RM, Ringel MD, Francis GL 2001 Thyroglobulin messenger ribonucleic acid levels in the peripheral blood of children with benign and malignant thyroid disease. Pediatr Res 49:429-434.
70. Biscolla RP, Cerutti JM, Maciel RM 2000 Detection of recurrent thyroid cancer by sensitive nested reverse transcriptionpolymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 85:3623-3627.
71. Bellantone R, Lombardi CP, Bossola M, Ferrante A, Princi P, Boscherini M, Maussier L, Salvatori M, Rufini V, Reale F, Romano L, Tallini G, Zelano G, Pontecorvi A 2001 Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: Results of a prospective study. Cancer 92:2273-2279.
72. Bojunga J, Roddiger S, Stanisch M, Kusterer K, Kurek R, Renneberg H, Adams S, Lindhorst E, Usadel KH, Schumm-Draeger PM 2000 Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer 82:1650-1655.
73. Savagner F, Rodien P, Reynier P, Rohmer V, Bigorgne JC, Malthiery Y 2002 Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients. J Clin Endocrinol Metab 87:635-639.
74. Kimoto Y 1996 A possibility of all mRNA expression in a human single lymphocyte. Hum Cell 9:367-370.
75. Chelly J, Concordet JP, Kaplan JC, Kahn A 1989 Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 86:2617-2621.
76. Bugalho MJ, Domingues RS, Pinto AC, Garrao A, Catarino AL, Ferreira T, Limbert E, Sobrinho L 2001 Detection of thyroglobulin mRNA transcripts in peripheral blood of individuals with and without thyroid glands: Evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 145:409-413.
77. Takano T, Miyauchi A, Yoshida H, Hasegawa Y, Kuma K, Amino N 2001 Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy. Br J Cancer 85:102-106.
78. Weber T, Lacroix J, Weitz J, Amnan K, Magener A, Holting T, Klar E, Herfarth C, von Knebel D 2000 Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction. Br J Cancer 82:157-160.
79. Jung R, Petersen K, Kruger W, Wolf M, Wagener C, Zander A, Neumaier M 1999 Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 81:870-873.
80. Saller B, Feldmann G, Haupt K, Broecker M, Janssen OE, Roggendorf M, Mann K, Lu M 2002 RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer. J Clin Endocrinol Metab 87:292-296.
81. Bojunga J, Dragan C, Schumm-Draeger PM, Usadel KH, Kusterer K 2001 Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma. Br J Cancer 85:1546-1550.
82. Taniguchi T, Makino M, Suzuki K, Kaibara N 2000 Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 89:970-976.
83. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M 1994 Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12:725-729.
84. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O 2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644-1650.
85. Saggiorato E, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, Angeli A, Orlandi F 2001 Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 86:5152-5158.
86. Weiss L 1990 Metastatic inefficiency. Adv Cancer Res 54:159-211.
87. Cameron MD, Schmidt EE, Kerkvliet N, Nadkarni KV, Morris VL, Groom AC, Chambers AF, MacDonald IC 2000 Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60:2541-2546.
88. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC 1998 Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865-873.